Literature DB >> 33401771

Metabolic Reprogramming of Cancer Cells during Tumor Progression and Metastasis.

Kenji Ohshima1, Eiichi Morii1.   

Abstract

Cancer cells face various metabolic challenges during tumor progression, including growth in the nutrient-altered and oxygen-deficient microenvironment of the primary site, intravasation into vessels where anchorage-independent growth is required, and colonization of distant organs where the environment is distinct from that of the primary site. Thus, cancer cells must reprogram their metabolic state in every step of cancer progression. Metabolic reprogramming is now recognized as a hallmark of cancer cells and supports cancer growth. Elucidating the underlying mechanisms of metabolic reprogramming in cancer cells may help identifying cancer targets and treatment strategies. This review summarizes our current understanding of metabolic reprogramming during cancer progression and metastasis, including cancer cell adaptation to the tumor microenvironment, defense against oxidative stress during anchorage-independent growth in vessels, and metabolic reprogramming during metastasis.

Entities:  

Keywords:  anchorage-independent growth; cancer metabolism; cancer metastasis; metabolic reprograming; therapeutic strategy; tumor microenvironments

Year:  2021        PMID: 33401771      PMCID: PMC7824065          DOI: 10.3390/metabo11010028

Source DB:  PubMed          Journal:  Metabolites        ISSN: 2218-1989


  176 in total

Review 1.  Dysregulated pH: a perfect storm for cancer progression.

Authors:  Bradley A Webb; Michael Chimenti; Matthew P Jacobson; Diane L Barber
Journal:  Nat Rev Cancer       Date:  2011-08-11       Impact factor: 60.716

2.  The nutrient environment affects therapy.

Authors:  Alexander Muir; Matthew G Vander Heiden
Journal:  Science       Date:  2018-06-01       Impact factor: 47.728

Review 3.  The steady-state kinetics of cytochrome c oxidation by cytochrome oxidase.

Authors:  C E Cooper
Journal:  Biochim Biophys Acta       Date:  1990-06-26

4.  The Acidic Tumor Microenvironment as a Driver of Cancer.

Authors:  Ebbe Boedtkjer; Stine F Pedersen
Journal:  Annu Rev Physiol       Date:  2019-11-15       Impact factor: 19.318

5.  Histone demethylase KDM6A directly senses oxygen to control chromatin and cell fate.

Authors:  Abhishek A Chakraborty; Tuomas Laukka; Matti Myllykoski; Alison E Ringel; Matthew A Booker; Michael Y Tolstorukov; Yuzhong Jeff Meng; Samuel R Meier; Rebecca B Jennings; Amanda L Creech; Zachary T Herbert; Samuel K McBrayer; Benjamin A Olenchock; Jacob D Jaffe; Marcia C Haigis; Rameen Beroukhim; Sabina Signoretti; Peppi Koivunen; William G Kaelin
Journal:  Science       Date:  2019-03-14       Impact factor: 47.728

6.  Direct evidence for cancer-cell-autonomous extracellular protein catabolism in pancreatic tumors.

Authors:  Shawn M Davidson; Oliver Jonas; Mark A Keibler; Han Wei Hou; Alba Luengo; Jared R Mayers; Jeffrey Wyckoff; Amanda M Del Rosario; Matthew Whitman; Christopher R Chin; Kendall J Condon; Alex Lammers; Katherine A Kellersberger; Brian K Stall; Gregory Stephanopoulos; Dafna Bar-Sagi; Jongyoon Han; Joshua D Rabinowitz; Michael J Cima; Robert Langer; Matthew G Vander Heiden
Journal:  Nat Med       Date:  2016-12-26       Impact factor: 53.440

7.  Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression.

Authors:  Chih-Hao Chang; Jing Qiu; David O'Sullivan; Michael D Buck; Takuro Noguchi; Jonathan D Curtis; Qiongyu Chen; Mariel Gindin; Matthew M Gubin; Gerritje J W van der Windt; Elena Tonc; Robert D Schreiber; Edward J Pearce; Erika L Pearce
Journal:  Cell       Date:  2015-08-27       Impact factor: 41.582

8.  Cofactors of serine racemase that physiologically stimulate the synthesis of the N-methyl-D-aspartate (NMDA) receptor coagonist D-serine.

Authors:  Joari De Miranda; Rogerio Panizzutti; Veronika N Foltyn; Herman Wolosker
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-22       Impact factor: 11.205

9.  Acidic extracellular microenvironment and cancer.

Authors:  Yasumasa Kato; Shigeyuki Ozawa; Chihiro Miyamoto; Yojiro Maehata; Atsuko Suzuki; Toyonobu Maeda; Yuh Baba
Journal:  Cancer Cell Int       Date:  2013-09-03       Impact factor: 5.722

10.  Circulating tumor cell clusters are oligoclonal precursors of breast cancer metastasis.

Authors:  Nicola Aceto; Aditya Bardia; David T Miyamoto; Maria C Donaldson; Ben S Wittner; Joel A Spencer; Min Yu; Adam Pely; Amanda Engstrom; Huili Zhu; Brian W Brannigan; Ravi Kapur; Shannon L Stott; Toshi Shioda; Sridhar Ramaswamy; David T Ting; Charles P Lin; Mehmet Toner; Daniel A Haber; Shyamala Maheswaran
Journal:  Cell       Date:  2014-08-28       Impact factor: 41.582

View more
  20 in total

1.  Hypoxia-Mediated ATF4 Induction Promotes Survival in Detached Conditions in Metastatic Murine Mammary Cancer Cells.

Authors:  Violet A Kiesel; Madeline P Sheeley; Emily M Hicks; Chaylen Andolino; Shawn S Donkin; Michael K Wendt; Stephen D Hursting; Dorothy Teegarden
Journal:  Front Oncol       Date:  2022-06-30       Impact factor: 5.738

Review 2.  Role of HIF-1α/ERRα in Enhancing Cancer Cell Metabolism and Promoting Resistance of Endometrial Cancer Cells to Pyroptosis.

Authors:  Pingping Su; Lirui Yu; Xiaodan Mao; Pengming Sun
Journal:  Front Oncol       Date:  2022-06-21       Impact factor: 5.738

3.  Identification of molecular subtypes and a novel prognostic model of diffuse large B-cell lymphoma based on a metabolism-associated gene signature.

Authors:  Jing He; Ziwei Chen; Qingfeng Xue; Pingping Sun; Yuan Wang; Cindy Zhu; Wenyu Shi
Journal:  J Transl Med       Date:  2022-04-25       Impact factor: 8.440

4.  Importance of Mevalonate Pathway Lipids on the Growth and Survival of Primary and Metastatic Gastric Carcinoma Cells.

Authors:  Natalia Ortiz; Juan Carlos Delgado-Carazo; Cecilia Díaz
Journal:  Clin Exp Gastroenterol       Date:  2021-05-31

5.  Loss of SDHB Induces a Metabolic Switch in the hPheo1 Cell Line toward Enhanced OXPHOS.

Authors:  Mouna Tabebi; Ravi Kumar Dutta; Camilla Skoglund; Peter Söderkvist; Oliver Gimm
Journal:  Int J Mol Sci       Date:  2022-01-05       Impact factor: 5.923

Review 6.  Metastasis and MAPK Pathways.

Authors:  Mateusz Kciuk; Adrianna Gielecińska; Adrianna Budzinska; Mariusz Mojzych; Renata Kontek
Journal:  Int J Mol Sci       Date:  2022-03-31       Impact factor: 5.923

7.  Bioenergetic and Metabolic Adaptation in Tumor Progression and Metastasis.

Authors:  Patries M Herst; Georgia M Carson; David A Eccles; Michael V Berridge
Journal:  Front Oncol       Date:  2022-03-17       Impact factor: 6.244

Review 8.  Sweet Cherries as Anti-Cancer Agents: From Bioactive Compounds to Function.

Authors:  Lara R S Fonseca; Gonçalo R Silva; Ângelo Luís; Henrique J Cardoso; Sara Correia; Cátia V Vaz; Ana P Duarte; Sílvia Socorro
Journal:  Molecules       Date:  2021-05-15       Impact factor: 4.411

Review 9.  The Nucleus/Mitochondria-Shuttling LncRNAs Function as New Epigenetic Regulators of Mitophagy in Cancer.

Authors:  Yan Li; Wei Li; Andrew R Hoffman; Jiuwei Cui; Ji-Fan Hu
Journal:  Front Cell Dev Biol       Date:  2021-09-08

10.  Novel long non-coding RNA CYB561-5 promotes aerobic glycolysis and tumorigenesis by interacting with basigin in non-small cell lung cancer.

Authors:  Longfei Li; Zhimin Li; Jingming Qu; Xiangju Wei; Feng Suo; Jilei Xu; Xiucheng Liu; Chang Chen; Shiying Zheng
Journal:  J Cell Mol Med       Date:  2022-01-22       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.